Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV

Trial Profile

Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV

Recruiting
Phase of Trial: Phase II

Latest Information Update: 30 Oct 2014

At a glance

  • Drugs Losartan (Primary)
  • Indications HIV-1 infections
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 20 Nov 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 11 Sep 2013 Planned initiation date changed from 1 Jul 2013 to 1 Nov 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top